R Schneppenheim Selected Research

R Schneppenheim Research Topics

Disease

20	von Willebrand Diseases (von Willebrand's Disease) 01/2016 - 04/2001
12	Hemorrhage 07/2014 - 12/2001
7	Thrombotic Thrombocytopenic Purpura 01/2014 - 01/2002
5	Type 1 von Willebrand Disease 09/2010 - 04/2006
2	Type 2 von Willebrand Disease 07/2014 - 01/2000
2	Type 3 von Willebrand Disease 07/2014 - 05/2011
2	Rhabdoid Tumor (Rhabdoid Tumors) 05/2014 - 03/2014
2	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 05/2014 - 07/2000
2	Thrombotic Microangiopathies 12/2007 - 02/2004
2	Thrombocytopenia (Thrombopenia) 02/2004 - 01/2002
1	Thrombosis (Thrombus) 06/2018
1	Hypersensitivity (Allergy) 01/2014
1	Thrombasthenia (Glanzmann Thrombasthenia) 01/2014
1	Hemophilia B (Haemophilia B) 01/2014
1	Spontaneous Abortion (Miscarriage) 05/2013
1	Rare Diseases (Rare Disease) 05/2013
1	Quadriplegia (Spastic Quadriplegia) 05/2009
1	Hemolytic-Uremic Syndrome 12/2007
1	Hepatorenal form of glycogen storage disease 01/2005
1	Evans Syndrome 02/2004
1	Hemophilia A (Haemophilia) 08/2002
1	Purpura 12/2001
1	Disseminated Intravascular Coagulation 12/2001
1	Vasculitis (Vasculitides) 12/2001
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2001
1	Infections 09/2001
1	Respiratory Tract Infections (Respiratory Tract Infection) 09/2001
1	Neuroblastoma 09/2001
1	Glycogen Storage Disease (Glycogenosis) 05/2001
1	Glycogen Storage Disease IIIA 05/2001
1	Hyperinsulinism (Hyperinsulinemia) 01/2001
1	Congenital Hyperinsulinism 01/2001
1	6 familial Hyperinsulinemic hypoglycemia 01/2001
1	Hyperammonemia 01/2001
1	Fanconi Anemia (Fanconi's Anemia) 07/2000
1	Lymphoma (Lymphomas) 02/2000

Drug/Important Bio-Agent (IBA)

23	von Willebrand FactorIBA 06/2018 - 01/2000
7	thiamine triphosphorate (TTP)IBA 01/2014 - 01/2002
4	Biomarkers (Surrogate Marker)IBA 09/2010 - 04/2006
3	AntigensIBA 01/2016 - 01/2005
3	Glycoproteins (Glycoprotein)IBA 07/2014 - 12/2001
3	ADAMTS13 ProteinIBA 05/2013 - 01/2002
2	DNA (Deoxyribonucleic Acid)IBA 07/2014 - 07/2000
2	AntibodiesIBA 11/2011 - 02/2000
2	Factor VIII (Coagulation Factor VIII)IBA 05/2011 - 08/2002
1	IsoantibodiesIBA 01/2014
1	Prothrombin (Factor II)IBA 01/2014
1	recombinant FVIIa (rFVIIa)FDA Link 01/2014
1	A-factor (Streptomyces)IBA 01/2014
1	Peptide Hydrolases (Proteases)FDA Link 11/2011
1	CollagenIBA 11/2011
1	Proteins (Proteins, Gene)FDA Link 07/2011
1	LatexIBA 09/2010
1	Protein SIBA 05/2009
1	LipidsIBA 01/2005
1	Inosine Triphosphate (ITP)IBA 02/2004
1	SolventsIBA 01/2002
1	Detergents (Detergent)IBA 01/2002
1	Dacarbazine (DIC)FDA LinkGeneric 12/2001
1	Hemostatics (Antihemorrhagics)IBA 12/2001
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 11/2001
1	FucoseIBA 09/2001
1	SolutionsIBA 09/2001
1	Galactose (Galactopyranose)FDA LinkGeneric 09/2001
1	LectinsIBA 09/2001
1	Anti-Bacterial Agents (Antibiotics)IBA 09/2001
1	SugarsIBA 09/2001
1	Glucan 1,4-alpha-GlucosidaseIBA 05/2001
1	Nonsense Codon (Nonsense Mutation)IBA 05/2001
1	Protein Subunits (Protein Subunit)IBA 04/2001
1	Leucine (L-Leucine)FDA Link 01/2001
1	EnzymesIBA 01/2001
1	Glutamate DehydrogenaseIBA 01/2001
1	MutagensIBA 07/2000

Therapy/Procedure

7	Therapeutics 05/2014 - 01/2002
3	Drug Therapy (Chemotherapy) 05/2014 - 09/2001
1	Radiotherapy 05/2014
1	Plasmapheresis 12/2007
1	Tooth Extraction (Tooth Extractions) 04/2006
1	Plasma Exchange 01/2002